Table of Contents
CONSHOHOCKEN, Pa. — Brian Nightengale has succeeded Dave Neu as president of AmerisourceBergen Corp.’s Good Neighbor Pharmacy.
Neu, who has also been executive vice president of retail strategy at AmerisourceBergen, will retire this summer after more than three decades with the company.
Nightengale had been president of Xcenda, AmeriscourceBergen’s health economics and outcomes consultancy. He has more than 20 years of experience with Xcenda, leading efforts to demonstrate the value of pharmaceutical products while improving patient access to medications. As an original Xcenda employee, he played a key role in growing the company from a start-up to a global leader in commercialization support for innovative medical treatments.
Prior to joining Xcenda, Nightengale served as an assistant professor at the University of Oklahoma Health Sciences Center College of Pharmacy, where he is a member of the national board of advisors.
“In today’s health care landscape, independent pharmacists are seeking partners who can help grow their business and their ability to meet the needs of patients in communities across the country,” said Bob Mauch, president of AmerisourceBergen Drug Corp. (ABDC). “Brian’s pharmacy background, deep understanding of the payer environment and clinical and commercial expertise will offer exciting new perspective for Good Neighbor Pharmacy and will enable us to honor Dave’s legacy by building the capabilities and solutions we need to support independent community pharmacists.”
Neu has held an array of leadership roles at AmerisourceBergen. In April 2011, he was promoted from senior vice president of operations to president of ABDC, the company’s pharmaceutical distribution business and biggest operating unit. He was named executive vice president of retail strategy and president of Good Neighbor Pharmacy in February 2015, with the promotion of Mauch from senior vice president and chief operating officer to president of ABDC. Throughout his tenure at AmerisourceBergen, Neu has passionately championed the value of independent community pharmacy to the health and pharmaceutical industry.
“Our company will continue to be inspired by Dave, and his legacy will be AmerisourceBergen’s unwavering focus on providing innovative and impactful support to community pharmacists,” commented Steven Collis, chairman, president and chief executive officer of AmerisourceBergen.
